Xeris Biopharma (XERS)
Markets Recorlev, Gvoke and Keveyis while advancing formulation-based drug programs.
$8.75
vs last close−0.05 (−0.63%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 60.19% | 109.74M shares | |
|---|---|---|---|
| 251 holders · as of Jun 30, 2026 | |||
| Insiders | 3.61% | 6.57M shares | |
| 13 holders · as of Sep 1, 2026 | |||
| Strategic holders | 5.49% | 10.01M shares | |
| 1 holder · as of Jan 26, 2024 | |||
| Other | 30.71% | 55.99M shares | |
| remainder | |||
182.32M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
251 holders · 109.74M shares · 38 new positions · 148 increased · 62 reduced · 29 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.53M | 7.97% | +1.58M | Aug 7, 2026 |
| D. E. Shaw & Co., Inc. | 7.80M | 4.28% | +15.9K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 7.34M | 4.03% | +359.3K | Aug 13, 2026 |
| State Street Corp | 4.82M | 2.64% | +163.4K | Aug 7, 2026 |
| Geode Capital Management, LLC | 4.72M | 2.59% | +427.6K | Aug 12, 2026 |
| Nuveen, LLC | 4.39M | 2.41% | +1.47M | Aug 11, 2026 |
| Rosalind Advisors, Inc. | 2.91M | 1.60% | −322.7K | Aug 14, 2026 |
| Qube Research & Technologies Ltd | 2.89M | 1.59% | −1.22M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 5.00% | 8.64M | 13G | Jul 31, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 1, 2026 | Steven Pieperofficer: See Remarks | Sale | 5,000 | $8.50 | 1,356,053 |
| Sep 1, 2026 | Beth Hechtofficer: See Remarks | Sale | 16,666 | $8.49 | 1,127,796 |
| Sep 1, 2026 | Kevin McCullochofficer: See Remarks | Sale | 15,000 | $8.49 | 1,639,208 |
| Aug 12, 2026 | Steven Pieperofficer: See Remarks | Sale | 5,000 | $8.50 | 1,361,053 |
| Aug 3, 2026 | Beth Hechtofficer: See Remarks | Sale | 16,666 | $8.01 | 1,144,462 |
| Aug 3, 2026 | Kevin McCullochofficer: See Remarks | Sale | 15,000 | $8.02 | 1,676,126 |
| Jul 7, 2026 | Steven Pieperofficer: See Remarks | Sale | 27,600 | $8.52 | 1,366,053 |
| Jul 6, 2026 | Steven Pieperofficer: See Remarks | Sale | 17,400 | $8.50 | 1,393,653 |
| Jul 1, 2026 | Beth Hechtofficer: See Remarks | Sale | 16,666 | $8.03 | 1,161,128 |
| Jul 1, 2026 | Kevin McCullochofficer: See Remarks | Sale | 90,000 | $8.03 | 1,691,126 |
House and Senate disclosures
Not reported.